1. Home
  2. CNTX vs MPU Comparison

CNTX vs MPU Comparison

Compare CNTX & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • MPU
  • Stock Information
  • Founded
  • CNTX 2015
  • MPU 1989
  • Country
  • CNTX United States
  • MPU Singapore
  • Employees
  • CNTX N/A
  • MPU N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • MPU Transportation Services
  • Sector
  • CNTX Health Care
  • MPU Consumer Discretionary
  • Exchange
  • CNTX Nasdaq
  • MPU Nasdaq
  • Market Cap
  • CNTX 75.6M
  • MPU 88.9M
  • IPO Year
  • CNTX 2021
  • MPU 1998
  • Fundamental
  • Price
  • CNTX $1.13
  • MPU $1.18
  • Analyst Decision
  • CNTX Strong Buy
  • MPU
  • Analyst Count
  • CNTX 7
  • MPU 0
  • Target Price
  • CNTX $5.20
  • MPU N/A
  • AVG Volume (30 Days)
  • CNTX 260.4K
  • MPU 896.7K
  • Earning Date
  • CNTX 11-05-2025
  • MPU 11-11-2025
  • Dividend Yield
  • CNTX N/A
  • MPU N/A
  • EPS Growth
  • CNTX N/A
  • MPU N/A
  • EPS
  • CNTX N/A
  • MPU N/A
  • Revenue
  • CNTX N/A
  • MPU $35,373,100.00
  • Revenue This Year
  • CNTX N/A
  • MPU N/A
  • Revenue Next Year
  • CNTX N/A
  • MPU N/A
  • P/E Ratio
  • CNTX N/A
  • MPU N/A
  • Revenue Growth
  • CNTX N/A
  • MPU 126.64
  • 52 Week Low
  • CNTX $0.49
  • MPU $0.49
  • 52 Week High
  • CNTX $2.59
  • MPU $4.44
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 69.12
  • MPU 33.97
  • Support Level
  • CNTX $0.98
  • MPU $1.18
  • Resistance Level
  • CNTX $1.29
  • MPU $1.36
  • Average True Range (ATR)
  • CNTX 0.09
  • MPU 0.12
  • MACD
  • CNTX 0.02
  • MPU 0.02
  • Stochastic Oscillator
  • CNTX 65.91
  • MPU 6.00

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About MPU Mega Matrix Corp.

Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: